Sign up


Match Document Document Title
8961937 Method for detecting amyloid aggregates using styrylpyridazine-one derivatives  
The present invention relates to a composition for detecting beta amyloid aggregates and a composition for diagnosing beta amyloid aggregation disease, comprising a 2-styrilpyridizine-3(2H)-one...
8961960 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases  
Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use...
8961948 Molecular surface design of tyrosine-derived polycarbonates for attachment of biomolecules  
Methods for constructing tyrosine-derived biotinylated polymers. Biotinylated polymers and polymer scaffolds constructed with the biotinylated polymers are also disclosed.
8962324 Method and system for treatment of biological tissue  
A composition for reconstruction, replacement or repair of damaged or diseased biological tissue comprising an extracellular matrix (ECM) composition that includes an ECM scaffold component and a...
8962031 Super paramagnetic iron oxide nanoparticles with metallic coatings and a method of synthesizing the same  
The various embodiments herein provide super paramagnetic iron oxide nanoparticles (SPIONs). The SPIONs have a plurality of metallic coatings and plurality of polymeric gaps. The embodiments herein...
8962669 Antimycotic pharmaceutical composition  
An object is to provide a medicament preparation which is excellent in the solubilization stability in relation to a compound represented by the general formula (1) during the storage in a low...
8962278 Compositions and methods for production of immunoglobulins  
Provided are oligonucleotides for isolating human antibody cDNAs from cells or cell lines, such as hybridomas. The invention also provides cDNAs that encode at least one provided CDR of a heavy...
8961988 Compositions and methods for the treatment or prevention of hepatitis B virus infection  
Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as...
8962005 Gastric reflux resistant dosage forms  
Gastric resistant film-forming compositions are described herein. The composition comprises a gastric resistant natural polymer, a film-forming natural polymer, and optionally a gelling agent....
8962043 Visual performance and/or macular pigmentation  
Disclosed is a composition comprising MZ for use as a dietary supplement or food additive for oral consumption for improving the visual performance of a human subject.
8962044 Radiopaque bone repair mixture and method of use  
A composition of a bone repair mixture has a quantity of allograft particulate bone having a bone particle distribution of particle sizes less than 700 micron and a quantity of biologic carrier...
8962011 Process and intra-cervical device for the local release of drugs in the local-regional treatment of cervical cancer  
An intrauterine device and more specifically an intracervical device (ICD) for the local release of drugs in the loco-regional treatment of tumours of the uterine cervix comprises an elongated stem...
8961990 Vaccine and methods to reduce campylobacter infection  
Vaccine vectors and methods for enhancing resistance to Campylobacter infection or for enhancing the immune response to Campylobacter are provided herein. The vaccine vectors include a first...
8962006 Composite mesh including a 3D mesh and a non porous film of oxidized cellulose from bacterial cellulose origin  
The present invention relates to a composite implant comprising: a prosthetic fabric having a first side and a second side, a non-porous film of bacterial cellulose secured to the first side of the...
8961945 Cationic polyglyceryl compositions and compounds  
Provided are polyglyceryl compositions comprising one or more polyglyceryl compounds having: (a) a node structure comprising at least three contiguous glyceryl remnant units; (b) one or more...
8962597 Alkyl ketal esters as dispersants and slip agents for particulate solids, methods of manufacture, and uses thereof  
Disclosed herein is a dispersion comprising a liquid or semi-solid continuous phase, a dispersed solid phase comprising a plurality of organic, inorganic or inorganic-organic particles, and an...
8961957 Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10  
The invention relates to therapy and methods of applying the therapy to cancer patients. The invention includes introducing intratumorally cytotoxic T lymphocyte and/or NKT cells, and prior to,...
8961969 Antagonist antibodies against EphB3  
EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating an...
8961987 Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies  
Insertion of HIV-1 V3 loop peptides from the viral glycoprotein gp120 into selected, immunogenic scaffold proteins results in a recombinant polypeptide that is a potent V3 immunogen. V3 immunogens...
8962699 Liquid composition to be filled in soft capsules  
Disclosed is a liquid composition which is intended to be filled in soft capsules and comprises an oil-insoluble ingredient dispersed in an edible oil, a reactive monoglyceride, and a triglycerol...
8962040 Vaporized medicants and methods of use  
A method and formulation for delivering an active compound in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that...
8962002 Alloplastic injectable dermal filler and methods of use thereof  
A composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent is...
8961978 Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses  
The present disclosure relates to binding molecules, such as human monoclonal antibodies, that bind to an epitope in the stem region of hemagglutinin of influenza A viruses of phylogenetic group 1...
8961963 Pharmacological composition whereby statin and COQ10 compounds are enhanced  
Disclosed is a pharmaceutical natural composition containing both statin compounds (mevinolin and mevinolinic acid) serving as cholesterol biosynthesis inhibitors and coenzyme Q (ubiquinone-10:...
8961986 Peptide composition  
There is provided a method for selecting a tolerogenic peptide by selecting a peptide which is capable of binding to an MHC class I or II molecule without further processing. There is also provided...
8962042 Methods for treating neurological disorders using nutrient compositions  
Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of...
8961961 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases  
Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use...
8962000 Microemulsion and sub-micron emulsion process and compositions  
An oil in water microemulsion or sub-micron emulsion composition for dermal delivery of at least one pharmaceutically active ingredient, is provided. The composition includes an oil phase dispersed...
8962559 Sustained release formulations comprising GNRH analogues  
The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention...
8961980 Monoclonal antibodies for treatment of cancer  
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including tumor-related diseases such as breast...
8962037 Dicalcium phosphate ceramics, dicalcium phosphate/hydroxyapatite biphasic ceramics and method of manufacturing the same  
The present invention discloses a method of manufacturing pure dicalcium phosphate ceramics or dicalcium phosphate/hydroxyapaite (HA) biphasic ceramics for medical applications in hard tissue areas...
8961942 Sunless tanning compositions with adjuvants comprising sulfur comprising moieties  
Sunless tanning compositions with adjuvants comprising sulfur comprising moieties are described. The compositions comprise an adjuvant with a +6 oxidation state sulfur moiety and results in...
8962012 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same  
The present invention is directed to a nonaqueous pressure-sensitive adhesive that may be used in medicinal tape preparations for percutaneous absorption. The adhesive may comprise a copolymer...
8961873 Antinfection protecting healthcare workers to prevent spreading of communicable and nosocomial infections  
The present invention describes a new system and method, named “Antinfection”, to protect primarily healthcare workers (HCWs) and patients against communicable and nosocomial infections. It's bas...
8961979 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use  
The present invention provides isolated polypeptides isolatable from a Staphylococcus spp. Also provided by the present invention are compositions that include one or more of the polypeptides, and...
8962036 Disintegrable formulations of lanthanum carbonate  
Disintegrable preparations of lanthanum carbonate prepared by co-precipitation, facilitating the manufacture of oral pharmaceutical dosage forms such as tablets, capsules, powders, granules, and...
8961991 Anti-CD40 targeted fusion proteins  
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to...
8961974 Multiple-variable dose regimen for treating TNFα-related disorders  
Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Mu...
8961962 Acid ceramidase and mammalian cell survival  
The present invention relates to methods of promoting the survival of cells by treating the cells with acid ceramidase. A kit for promoting ex vivo cell survival is also disclosed, as is a method...
8962024 Method for treating primary insomnia  
The invention relates to a medicament, for treating and improving the restorative quality of sleep, in a patient suffering from primary insomnia, which comprises at least one compound selected from...
8961968 Human monoclonal antibodies against CD25  
Isolated human monoclonal antibodies which bind to and inhibit human CD25, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a hybridoma,...
8961926 Method of imaging localized infections  
The invention relates to a method for targeting an imaging agent to cells of an animal to detect localized infections. More particularly, localized infections are detected by targeting imaging...
8962689 Medium chain dicarboxylic acids, their derivates and metabolic disorders  
The present invention relates in general to medium chain dicarboxylic acids, their derivatives and their uses. In particular, the present invention relates to a composition comprising medium chain...
8961681 Process for the preparation of nano zinc oxide particles  
A process for the preparation of nano zinc oxide particles is disclosed. The process comprises of dissolving a zinc metal precursor in a solvent to obtain a first solution and dissolving a base in...
8962565 Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same  
Peptide compounds of general formula (I) R1-(AA)n-X1—X2—X3-Asp-Leu-Lys-Lys-X4—X5-(AA)p-R2, cosmetic or pharmaceutical compositions comprising at least one peptide compound of general formula (I) i...
8962001 Nuclease inhibitors and methods for their use  
A class of anionic oligomers and polymers that function for inhibition of nucleases, particularly RNase. Specific inhibitors include mixtures of oligomers of vinyl sulfate. Methods for inhibition...
8961946 Hair processing agent and method for permanent waving hair  
Provided are hair processing agents capable of permanent waving hair even at a neutral to weakly acidic pH range that causes less irritation to the skin, and hair processing agents in which an...
8962317 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration  
The present application relates to stem cells isolated from various sources within the body of a patient or of a healthy donor and identified by the presence of the interleukin 12 (IL-12) receptor....
8961498 Electronic pill comprising a plurality of medicine reservoirs  
Electronic pill (1, 11, 21) comprising a plurality of medicine reservoirs (2, 12, 22), each of the reservoirs comprising a discharge opening (3, 13, 23) covered by a removable cover (6, 16, 26)....
8961929 Targeting agent for tumor site  
It is an object of the present invention to provide a targeting agent, which enables the delivery of a drug to tumor sites or the imaging of tumor sites by utilizing its effect of accumulating to...